,AnilKD’Cruz ,PankajChaturvedi ,AnaghaKakade ,SubhadraVKane RohanRWalvekar ,DevendraAChaukar ,MandarSDeshpande ,PrathameshSPai Verrucouscarcinomaoftheoralcavity:Aclinicalandpathologicalstudyof101cases

Download (0)

Full text


Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases

Rohan R Walvekar


, Devendra A Chaukar


, Mandar S Deshpande


, Prathamesh S Pai


, Pankaj Chaturvedi


, Anagha Kakade



Subhadra V Kane


, Anil K D’Cruz


aDepartment of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India

bDepartment of Otolaryngology and Head Neck Surgery, University of Pittsburgh, PA 15213, United States

cClinical Research Secretariat, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India

dDepartment of Pathology, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India

Received 18 February 2008; received in revised form 17 March 2008; accepted 18 March 2008 Available online 11 July 2008

KEYWORDS Ackerman’s tumor;

Verrucous carcinoma;

Oral cavity;


Summary This paper studies the clinical and pathological predictors of local recurrence and disease-free survival (DFS) in patients with oral verrucous carcinoma (OVC) treated surgically, through a retrospective chart review. Three hundred and two patients with OVC were identified from January 1990 to December 2000, of which, 101 surgically treated patients who fulfilled our inclusion criteria were analyzed. A univariate analysis (UVA) of important prognostic factors, patterns of recurrence, and DFS is reported. Seventy-nine patients were male (M:F ratio, 3.6:1) and the mean age at presentation was 53.9 years (range, 23–90 years). The median fol- low up was 4.61 years (range, 0.51–14.3 years). The incidence of tobacco chewing, smoking, and alcohol intake was 77%, 42%, and 10%, respectively. Thirty-four patients (33.7%) had either leukoplakia or submucous fibrosis (SMF) on oral cavity examination. Early-stage tumors accounted for 39.7%; while 60.4% were late-stage tumors. On UVA, tumor location, presence of a premalignant lesion, smoking, and positive margins were statistically significant. Sixty- eight percent (19/28) recurred locally. The salvage rate for recurrent tumors was 66.7% (16/

28) with a median post-recurrence survival of 16 months (range, 10–83 months). The five year DFS with surgical therapy was 77.6%. OVC has an excellent prognosis with surgical treatment.

The significance of positive margins emphasizes the need for adequate surgical resection. Addi- tionally, the presence of either leukoplakia or SMF and tumor location in the upper alveolar-pal- atal complex is associated with worse outcomes. Neck dissection, if considered, may be limited to a supra-omohyoid neck dissection (SOHND).

ª 2008 Elsevier Ltd. All rights reserved.

1368-8375/$ - see front matter ª 2008 Elsevier Ltd. All rights reserved.


* Corresponding author. Tel.: +91 22 24177278; fax: +91 22 24158989.

E-mail addresses:adcruz@vsnl.com,docdcruz@gmail.com(A.K D’Cruz).

a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m

j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / o r a l o n c o l o g y



OVC is a rare variant of oral SCC. In 1948, Lauren V. Acker- mann first described this neoplasm of the oral mucous mem- brane, which is now also know as ‘‘Verrucous carcinoma of Ackermann’’ or ‘‘Ackermann’s tumor’’.1The oral cavity is the most common site of occurrence. In addition, it is known to occur in the larynx, pyriform sinus, esophagus, na- sal cavity and paranasal sinuses, external auditory meatus, lacrimal duct, skin, scrotum, penis, vulva, vagina, uterine cervix, perineum, and the leg.2,3 This tumor is predomi- nantly seen in males over the sixth decade. In terms of tu- mor biology, OVC is distinct in its slow growth and ability to become locally aggressive if not treated appropriately.

However, even with local tumors progression, it is intriguing that regional or distant metastasis is rare.4OVC has unique histopathological features. An accurate pathological diag- nosis is challenging and is facilitated by an adequate tumor sample for study and more importantly, a close collabora- tion between the clinician and the pathologist.4,5

The etiopathogenesis of OVC is unclear, however, studies have shown strong associations with tobacco use, including inhaled as well as smokeless tobacco, alcohol, and oppor- tunist viral activity associated with human papilloma virus (HPV).4,6–8More recently, studies have further confirmed the association between HPV and OVC by detecting HPV–

DNA types 6, 11, 16 , and 18 by polymerase chain reaction (PCR), restriction fragment analysis, and DNA slot–blot hybridization.9–11 Surgical excision with adequate margins of resection seems to be the clear preference for treat- ment. Recurrences are frequent and require additional treatments.2,6To date, the literature focusing on the clini- copathological features of OVC is not robust. Our aim was to study the clinical and pathological predictors of local recur- rence and DFS in large cohort of patients with OVC treated surgically at one institution.

Materials and methods

A retrospective chart review was conducted at the a tertiary cancer institute for patients presenting with OVC over a 11 year period, i.e., January 1, 1990–December 31, 2000. Prior to embarking on this study; an approval from the hospital was obtained as per protocol. Three hundred and two con- secutive cases diagnosed with OVC on histopathological examination were identified. The histological criteria em- ployed for diagnosis of OVC required to tumor to have a well differentiated squamous proliferation exhibiting both exo- phytic and endophytic components and orderly maturation.

The exophytic components were composed of papillae cov- ered by orthokeratin and/or para keratin. The endophytic components were made up of typically broad, blunt rete pegs with pushing margins. The advancing edge of the tu- mors were well differentiated with minimal cytologic aty- pia. Subepithelial tissue contained lymphoplasmacytic inflammatory infiltrate.1,5,12,13 Patients treated primarily with surgery, with no prior history of head and neck cancer treatment were included in the analysis. Patients with recurrent tumors and distant metastasis were excluded. In addition, patients with hybrid tumors (tumors containing

components of both verrucous and squamous carcinoma) and verrucous hyperplasia were also excluded from the analysis. The final analysis was conducted on 101 patients with pathologically proven OVC who fulfilled our inclusion criteria. Statistical analysis was performed using the SPSS software version for 11.5 for Windows. Survival curves were plotted by the Kaplan–Meier method and compared by the log-rank test.


There were 79 males and 22 females (ratio M:F, 3.6:1), with a mean age of 53.9 years (age range, 23–90 years). The median follow up for the entire surgical cohort was 4.61 years (range, 0.51–14.3 years). The incidence of tobacco chewing, smoking, and alcohol intake was 76.2% (77/101), 41.6% (42/101), and 9.9% (10/101), respectively. Due to the retrospective nature of this study, a history of the quan- tity, frequency, and duration of tobacco chewing, smoking, and alcohol usage could not be obtained in sufficient detail to merit further analysis. Among these patients 58% had t one of the three risk factors, while 32% had multiple risk factors. Thirty-four patients (33.7%) had either leukoplakia (18/34; 53%), SMF (12/34; 35.2%), or both lesions (4/34;

11.8%) on oral cavity examination. At presentation, the epi- center of the disease was most frequently the buccal muco- sa, seen in 62 patients (61.4%), followed by the lower alveolus in 12 patients (11.9%) (Table 1). The most common morphological presentation was a ‘proliferative’ lesion fol- lowed by a ‘verrucous’ or ‘wart-like’ growth (Table 2).

The T and N distribution for the entire study cohort is sum- marized inTable 3. The patients were staged according to the AJCC staging system.14 Early-stage tumors accounted for 39.7% [stage I, 5% (5/101) and stage II, 34.7% (35/

101)], while late-stage tumors accounted for 60.4% of all tumors [stage III, 32.7% (33/101) and stage IV 27.7% (28/

101)]. All patients were treated with curative intent; 82%

had surgery alone and 18% received surgery and postopera- tive radiotherapy.

Seventy patients (69.3%) were clinically N0 at presenta- tion. Neck dissections were performed in 52 patients.

Among the patients who had neck dissection, 48% (25/52) had palpable nodes at presentation. In addition, among pa- tients with N0 necks who had neck dissection (27/52; 52%);

all patients had tumor size equal to or greater than T2 at presentation. Radical neck dissections, modified radical neck dissections, and supra-omohyoid neck dissections

Table 1 Distribution of primary tumors by epicenter at presentation

Epicenter Frequency (N = 101) (%)

Buccal mucosa 62 (61.4)

Lower alveolus 12 (11.9)

Lower GBS 10 (9.9)

Upper alveolus 06 (5.9)

Anterior oral tongue 05 (5.0)

Lip 04 (4.0)

RMT 01 (1.0)

Palate 01 (1.0)


(SOHND) were performed in 19.8% (20/52), 4% (4/52), and 27.7% (28/52), respectively. None of our patients had met- astatic lymphadenopathy. The incidence of pathological bone involvement was 5.9% (6 patients). Out of the 16 patients with clinical impression of bone involvement, only six (37.5%) with clinical had pathological evidence of bony invasion. Two patients had muscle invasion, while skin involvement and soft tissue infiltration was found in five and three patients, respectively. None of the patients had evidence of PNI or lymphovascular invasion.

On UVA, smoking was found to impact the DFS. Tobacco chewing, alcohol consumption as well as the presence of multiple habits were not found to be statistically significant.

Primary site of cancer was not statistically significant when the epicenter of tumor presentation were considered inde- pendently. However, when tumors were distributed into well established groups such as the gingivobuccal complex (GBC), oral anterior tongue, and upper alveolar-palatal

complex; the primary site was found to be statistically sig- nificant for DFS. The rate of recurrence among patients with tumors of GBC, oral anterior tongue, and upper alveolar- palatal complex tumors was 26% (23/88), 57% (4/7), and 40% (2/5), respectively. The presence of premalignant le- sions and positive margins were also found to be of statisti- cal significance (Table 4). The overall rate of recurrence was 28%. The majority of patients failed locally, 19 (68%), i.e. [pure local failures were 16 (57%) and loco-regional fail- ures were 3 (11%). The incidence of second primary cancer for this patient cohort was found 6.9% (7/101), (Table 5).

The salvage rate after recurrence for our cohort of patients was 66.7% (16/28). The median post-recurrence survival was 16 months (range, 10–83 months). The 5-year DFS for the entire cohort was 77.6%.


There are very few studies, especially from developing countries such as India, which have evaluated the clinical and pathological prognostic factors relevant to local recur- rence and DFS for OVC. OVC traditionally occurs more com- monly in older males, above the sixth decade.4We observed similar demographics wherein the male patients were more preponderant and the mean age at presentation was be- tween the fifth and sixth decade. Although there is a striking male preponderance to OVC, there are studies where equal sex distribution15and female predominance has been dem- onstrated.6,16Tobacco chewing is a significant etiologic fac- tor for the development of OVC.2Lesions often develop at the site where the tobacco was placed habitually.13In Ack- erman’s study, 11 out of 18 patients (61%) with buccal can- cers were tobacco chewers. Majority of our patients (76.2%) chewed tobacco and had buccal cancer. Interestingly, to- bacco chewing was not statistically significant for DFS in our analysis. We hypothesize that the true effects of tobac- co chewing were confounded by smokers, since 62.3% (48/

77) of tobacco chewers had a history of smoking as well.

This hypothesis is further validated by the fact that the UVA demonstrated smoking to be of statistical significance (p = 0.0431) impacting DFS. The strong association of OVC with smoking, alcohol, and HPV infections is well known.4,6–8. Jacobson and Shear surveyed 198 cases of OVC and described 15 personally-observed cases, where incidence of smoking was found to be 77% (7 out of 9 pa- tients).7 However, their study was purely observational and could not offer any evidence to emphasize the rele- vance of smoking as an etiological factor for OVC. Although, alcohol has been described as a predisposing factor in oral cancer; previous studies as well as our analysis could not validate its association to OVC.6

Table 2 Morphological presentation of OVC

Morphology of tumor Frequency (%)

Proliferative 35 (34.7)

Verrucous 34 (33.7)

Ulceroproliferative 18 (17.8)

Ulcerative 10 (9.9)

Submucous/infiltrative 02 (2.0)

Not recorded 02 (2.0)

Table 3 T and N distribution for the study cohort

N0 N1 N2a N2b

T1 5 1 0 0 6

T2 35 6 0 1 42

T3 19 7 0 0 26

T4a 11 12 1 3 27

70 26 1 4 101

Table 4 UVA: prognostic factors for OVC

Age (640 years vs. >40 years) 0.9979 NS

Tobacco chewing 0.6771 NS

Smoking 0.0431*

Alcohol consumption 0.1154 NS

SMF 0.1671 NS

Leukoplakia 0.5241 NS

SMF or Leukoplakia or Both 0.0252*

Primary site 0.0000*

Morphological type of lesion (clinical) 0.3568 NS

Clinical T size 0.5432 NS

Clinical lymphadenopathy 0.6845 NS

Clinical Stage 0.6600 NS

Neck dissection 0.1658 NS

Pathological T size 0.6303 NS

Pathological bone invasion 0.3546 NS

Positive cut margins 0.0497*

Table 5 Patterns of recurrence

Site of recurrence Frequency (% of recurrent tumors)

Local 16 (55.2)

Regional 02 (6.9)

Locoregional 03 (10.3) Second primary tumors 07 (24.1) Distant metastasis 01 (3.4)


Oral SCC and OVC are known to be associated with poor dental hygiene, ill-fitting dentures, low socioeconomic sta- tus, tobacco chewing, snuff and alcohol use, and smok- ing.4,7,12 These are the same factors that predispose individuals to the development of premalignant lesions such as, leukoplakia, submucous fibrosis (SMF), and erythropla- kia.17 In the present study, 33.7% (34/101) patients had either leukoplakia, SMF or both lesions on oral cavity exam- ination. Extensive leukoplakia and premalignant changes have been noted in other studies as well. Rajendran et al.

recorded leukoplakia in association with OVC in 48% of their patients.5,13 The clinical association with leukoplakia and OVC is significant since untreated longstanding leukoplakia could progress to a verrucous cancer in time.16The synchro- nous presentation of either a leukoplakia or SMF in associa- tion with an OVC was found to statistically impact DFS and local recurrence in our series (p = 0.0252).

As previously mentioned, the epicenter of OVC was most commonly the buccal mucosa (61.4%), followed by the lower alveolus (11.9%). These findings are in lieu with current liter- ature, which suggest that verrucous carcinoma has a predi- lection for the oral cavity; in particular the buccal mucosa and the lower alveolus.5,7,16,18 In addition, tumor location was statistically significant with worst outcomes for tumors involving the upper alveolus and palate. Although, this is consistent with our clinical experience, the statistical limi- tation to this observation is that upper alveolar-palatal tu- mors comprised of 6.9% of the study cohort.

OVC has a characteristic gross appearance. These lesions are almost always large, exophytic, soft, fungating, slow growing neoplasms with a pebbly mamillated surface (Fig. 1).1,5Though this is the most commonly presentation of OVC; we did observe other types of morphological pre- sentations as well. Although the gross appearance was not statistically significant factor in the UVA; it must be borne in mind that OVC may not always appear as the typical warty exophytic lesion described in the literature.

Majority of the tumors presented with advanced stage (60.4%, stage III–IV). Clinical stage was not found to be an important prognostic factor on UVA. In general, OVC are

locally aggressive, but have a low propensity for regional as well as distant metastasis.4 Thirty-one patients in our study group presented with clinically palpable neck nodes.

Among OVC, most enlarged lymph nodes at presentation are often reactive to a secondary infection or inflammation rather than true metastasis.6,7This is supported by the fact that none of our patients undergoing neck dissections had pathologically positive nodes. It must be noted that although it is a rare occurrence, metastasis from OVC has been reported. Ackerman reported one patient with a histo- logical positive lymph node metastasis.1 Similarly, Duck- worth encountered a single node metastasis in one of his three patients.19

The need for neck dissection is an important consider- ation in planning therapy for OVC. The aggressive clinical presentation of the tumor often sways clinical judgment in favor of performing lymph node dissection, especially in the presence of clinical lymphadenopathy. This sentiment is reinforced by the fact that OVC is an extremely challeng- ing pathological diagnosis and often even an adequate biopsy may miss areas of squamous differentiation. However, data from the present study as well as other studies, suggest that lymph node dissection in OVC should be confined to immedi- ately adjacent lymph node groups only and in cases, where any possibility of increased morbidity or mortality may arise from inclusion of neck dissection with surgical excision, it could be omitted entirely. It is reasonable to consider a selective neck treatment such as a SOHND in situations where there is uncertainty regarding the pathological diag- nosis in the face of clinically suspicious lymphadenopathy.

Alternatively, a staged neck procedure is also a reasonable option if final tumor histology mandates it.

OVC tends to destroy bony structures such as the mandi- ble, on a broad front, eroding with a sharp margin rather infiltrating the marrow spaces.13The incidence of patholog- ical bone involvement in our study was 5.9% and was not sta- tistically significant in our study. Rajendran et al., in their study of 426 cases of OVC, found the incidence of bone inva- sion to be 1.2%.5Oliveira et al. did not find bone invasion in their series.4Given the low incidence of pathological bone involvement; more conservative surgical options such as marginal mandibular resection may be considered while planning surgical therapy in these patients.

In our study, positive surgical margins was found to be statistically significant (p = 0.0497). Local recurrences can be attributed to inadequate surgical resection, which may be influenced by several factors. In extensive tumors with inflammatory changes, the margins may be difficult to de- fine and frozen sections at surgery could be false negative.6 It has also been proposed that the slow growth of OVC and lower invasive potential could induce inadequate surgical resections, compromising surgical margins.7,19However, it is noteworthy that local recurrences are observed despite clear surgical margins confirmed by histopathology.4Slaugh- ter et al. emphasized the fact that in situ carcinoma in- volves the mucosa over wide surface area than in depth.

The presence of carcinoma in situ microscopically in clini- cally negative resections can explain the phenomenon of recurrence of invasive cancer in apparently normal epithe- lium or previous excision sites.20Ackerman’s reasoning mir- rored this concept of ‘‘field cancerization’’ proposed by Slaughter; which could explain the high local recurrence Figure 1 OVC presenting in the left buccal mucosa.


rates, second primary tumors and the occurrence of OVC at multiple sites.4,21,22

In the present study, the overall recurrence rate (28%) is comparable to the range reported in the literature, 6.12–

40%.7,20 The incidence of second primary cancer (6.9%) observed was lower than figures reported in other studies (10%).4,13 In spite of a high incidence of local recurrence, OVC is often amenable to re-resections. This is exemplified by our high salvage rate for recurrent tumors (66.7%) and an excellent post-recurrence survival (range, 10–83 months).

The five years disease-free survival with surgical therapy was found to be 77.6% which correlates well with control rates reported in the literature.7


OVC have an excellent prognosis with surgical management.

The significance of positive margins emphasizes the need for surgical resection with adequate margins. The high inci- dence of local recurrences and propensity to developing second primary cancers makes it incumbent upon us to fol- low these patients closely. OVC are most commonly seen within the GBC, however OVC involving the hard palate and upper alveolus to be more aggressive. If the pathological diagnosis is uncertain, it is reasonable to consider neck treatment if the presence of clinical lymphadenopathy.

Upfront neck dissection, if considered, may be limited to SOHND. The presence of leukoplakia or SMF in addition to OVC could indicate a predisposition for multi-centricity,

‘‘field cancerization’’, and higher local recurrence making a stronger argument for prolonged close follow up in these patients.

Source of Funding

None declared.

Conflict of Interest Statement

None declared.


The authors thank Mr. Gopu Natarajan (Department of Med- ical Records, Tata Memorial Hospital), for his support and help in getting the necessary medical records to conduct the retrospective review.


1. Ackerman L. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670–8.

2. Spiro RH. Verrucous carcinoma, then and now. Am J Surg 1998;176(5):393–7.

3. Ferlito A, Recher G. Ackerman’s tumor (verrucous carcinoma) of the larynx: a clinicopathologic study of 77 cases. Cancer 1980;46(7):1617–30.

4. Oliveira DT, de Moraes RV, Fiamengui Filho JF, Fanton Neto J, Landman G, Kowalski LP. Oral verrucous carcinoma: a retro- spective study in Sao Paulo Region, Brazil. Clin Oral Invest 2006;10(3):205–9.

5. Rajendran R, Sugathan CK, Augustine J, Vasudevan DM, Vija- yakumar T. Ackerman’s tumour (verrucous carcinoma) of the oral cavity: a histopathologic study of 426 cases. Singapore Dent J 1989;14(1):48–53.

6. Tornes K, Bang G, Stromme Koppang H, Pedersen KN. Oral verrucous carcinoma. Int J Oral Surg 1985;14(6):485–92.

7. Jacobson S, Shear M. Verrucous carcinoma of the mouth. J Oral Pathol 1972;1(2):66–75.

8. Sundstrom B, Mornstad H, Axell T. Oral carcinomas associated with snuff dipping. Some clinical and histological characteris- tics of 23 tumours in Swedish males. J Oral Pathol 1982;11(3):245–51.

9. Shroyer KR, Greer RO, Fankhouser CA, McGuirt WF, Marshall R.

Detection of human papillomavirus DNA in oral verrucous carcinoma by polymerase chain reaction. Mod Pathol 1993;6(6):669–72.

10. Lubbe J, Kormann A, Adams V, et al. HPV-11- and HPV-16- associated oral verrucous carcinoma. Dermatology 1996;192(3):217–21.

11. Noble-Topham SE, Fliss DM, Hartwick RW, et al. Detection and typing of human papillomavirus in verrucous carcinoma of the oral cavity using the polymerase chain reaction. Arch Otolar- yngol Head Neck Surg 1993;119(12):1299–304.

12. Kraus FT, Perezmesa C. Verrucous carcinoma. Clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966;19(1):26–38.

13. Shear M, Pindborg JJ. Verrucous hyperplasia of the oral mucosa. Cancer 1980;46(8):1855–62.

14. American Joint Committee on Cancer (AJCC). In: Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al., editors. Cancer staging manual. 6th ed. Heidelberg: Springer;


15. Fonts EA, Greenlaw RH, Rush BF, Rovin S. Verrucous squamous cell carcinoma of the oral cavity. Cancer 1969;23(1):


16. Demian SD, Bushkin FL, Echevarria RA. Perineural invasion and anaplastic transformation of verrucous carcinoma. Cancer 1973;32(2):395–401.

17. Tharp 2nd ME, Shidnia H. Radiotherapy in the treatment of verrucous carcinoma of the head and neck. Laryngoscope 1995;105(4 Pt 1):391–6.

18. Hashibe M, Jacob BJ, Thomas G, et al. Socioeconomic status, lifestyle factors and oral premalignant lesions. Oral Oncol 2003;39(7):664–71.

19. Duckworth R. Verrucous carcinoma presenting as mandibular osteomyelitis. Brit J Surg 1961;49:332–7.

20. Ackerman LV, Mc GM. Proliferating benign and malignant epithelial lesions of the oral cavity. J Oral Surg (Chic) 1958;16(5):400–13.

21. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6(5):963–8.

22. Rajendran R, Varghese I, Sugathan CK, Vijayakumar T. Acker- man’s tumour (verrucous carcinoma) of the oral cavity: a clinico-epidemiologic study of 426 cases. Aust Dent J 1988;33(4):295–8.




Related subjects :